How’s the STAY study going? Here’s an update from the vet who designed it.
Loyal Blog
by
3w ago
How’s the STAY study going? Here’s an update from the vet who designed it ..read more
Visit website
Same drugs, different species: How the effects of drugs vary between dogs and humans
Loyal Blog
by
1M ago
Many medications are used for both dogs and humans, but their effects can be quite different. Curious about why the effects vary so much between species? Dr. Brennen McKenzie teaches us about these fascinating differences ..read more
Visit website
Great Danes and granddads: How 'one medicine' is redefining healthy longevity
Loyal Blog
by
1M ago
Because our dogs share our environments and age like we do, we can learn about ourselves through our canine best friends — this is called translational medicine. Read about how the connection between us and our dogs can improve the health of both species ..read more
Visit website
Drugs and dietary supplements for dogs: What’s the difference?
Loyal Blog
by
2M ago
Did you know there are several categories of medicines that your vet chooses from when prescribing a treatment to your dog? Each option comes with a different amount of evidence regarding risks and benefits. The FDA offers guidelines to help weigh the benefits and risks, making it easier for you and your vet to choose the right treatment ..read more
Visit website
Can science actually make your dog live longer? — the Purina study
Loyal Blog
by
3M ago
Caloric restriction has been shown to extend dogs’ lifespans and improve their metabolic health, demonstrating that aging can be slowed — and we can do something about it. This knowledge drives research into more practical ways to achieve these benefits ..read more
Visit website
What is FDA conditional approval?
Loyal Blog
by
6M ago
Expanded conditional approval is a new regulatory pathway that allows drugs to go to market more quickly, with the same rigorous safety standards ..read more
Visit website
$125M to extend dog lifespan
Loyal Blog
by
8M ago
Today we are announcing Loyal’s $45M Series B. Thank you, Wall Street Journal, for the excellent piece. This round brings Loyal’s total financing to over $125M. It is the honor of a lifetime to build Loyal with this team of scientists, veterinarians, creatives, operators, animal lovers, and investors ..read more
Visit website
Enrolling your dog in the STAY study
Loyal Blog
by
9M ago
Everything you need to know about study requirements and sites open for enrollment ..read more
Visit website
Meet Boo — the first dog dosed in our LOY-002 pivotal study for extending healthy lifespan in dogs of nearly all sizes
Loyal Blog
by
9M ago
The STAY study will span more than 50 sites across the country, with 1,000 senior dogs participating ..read more
Visit website
FDA Center for Veterinary Medicine agrees Loyal’s data supports reasonable expectation of effectiveness for large dog lifespan extension
Loyal Blog
by
11M ago
A historic milestone in developing the first drug for healthy lifespan extension in dogs ..read more
Visit website

Follow Loyal Blog on FeedSpot

Continue with Google
Continue with Apple
OR